NCT02013388View on ClinicalTrials.gov

MAD Study Evaluating the Safety, Tolerability, and Pharmacokinetic Effects of N91115 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

February 28, 2015

Conditions
Healthy
Interventions
DRUG

N91115

Given PO daily for 14 days

DRUG

Placebo

Given PO daily for 14 days

DRUG

N91115

Given PO only on Day 1

DRUG

Placebo-Day 1 only

Given PO- only on Day 1 (single dosed to match single dose treatments)

Trial Locations (1)

80228

DaVita Clinical Research, Lakewood

Sponsors
All Listed Sponsors
lead

Nivalis Therapeutics, Inc.

INDUSTRY

NCT02013388 - MAD Study Evaluating the Safety, Tolerability, and Pharmacokinetic Effects of N91115 in Healthy Subjects | Biotech Hunter | Biotech Hunter